Harnessing gene power to make
treatment accessible to all
About AnGes
News
All
Development
Product Info
IR
Information
- 2026.07.28Development
- Vasomune Therapeutics, Our Development Partner, to Present on the Therapeutic Potential of the Tie2 Receptor Agonist (AV-001) at the 2026 NATO NSPA CBRN Conference
- 2026.07.22Development
- Vasomune Therapeutics, Our Development Partner, to Present on Vascular Leak in Combat-Related Injuries at the 2026 Military Health System Research Symposium (MHSRS)
- 2026.07.17Development
- Notice Regarding the Pre-BLA Meeting and BLA Submission for the HGF Gene Therapy Product
- 2026.07.01Development
- Announcement of Award at Asia Pacific Cell ＆ Gene Therapy Excellence Awards 2026
- 2026.06.05IR
- FISCO’s Corporate Reports